CLARANOVA SE (CLA.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:CLA - FR0013426004 - Common Stock
1.426 EUR
+0 (+0.28%)
Taking everything into account, CLA scores 3 out of 10 in our fundamental rating. CLA was compared to 115 industry peers in the Software industry. There are concerns on the financial health of CLA while its profitability can be described as average. CLA has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CLA has reported negative net income.
In the past year CLA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
In the past 5 years CLA always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -1.14%, CLA is not doing good in the industry: 60.53% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for CLA is above the industry average of 12.49%.
The last Return On Invested Capital (%ROIC%%) for CLA is well below the 3 year average (16.83%), which needs to be investigated, but indicates that CLA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.14% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
1.3 Margins
In the last couple of years the Profit Margin of CLA has grown nicely.
CLA has a better Operating Margin (10.11%) than 60.53% of its industry peers.
In the last couple of years the Operating Margin of CLA has grown nicely.
With a Gross Margin value of 48.54%, CLA is not doing good in the industry: 71.05% of the companies in the same industry are doing better.
CLA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.11% | ||
| PM (TTM) | N/A | ||
| GM | 48.54% |
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLA is creating value.
Compared to 1 year ago, CLA has more shares outstanding
CLA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLA has an improved debt to assets ratio.
2.2 Solvency
CLA has an Altman-Z score of -0.25. This is a bad value and indicates that CLA is not financially healthy and even has some risk of bankruptcy.
CLA's Altman-Z score of -0.25 is on the low side compared to the rest of the industry. CLA is outperformed by 79.82% of its industry peers.
The Debt to FCF ratio of CLA is 5.38, which is a neutral value as it means it would take CLA, 5.38 years of fcf income to pay off all of its debts.
CLA has a Debt to FCF ratio of 5.38. This is comparable to the rest of the industry: CLA outperforms 51.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.38 | ||
| Altman-Z | -0.25 |
ROIC/WACCN/A
WACC7.33%
2.3 Liquidity
CLA has a Current Ratio of 0.50. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.50, CLA is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
A Quick Ratio of 0.45 indicates that CLA may have some problems paying its short term obligations.
CLA has a worse Quick ratio (0.45) than 90.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.5 | ||
| Quick Ratio | 0.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 40.05% over the past year.
Measured over the past years, CLA shows a very strong growth in Earnings Per Share. The EPS has been growing by 152.38% on average per year.
The Revenue for CLA has decreased by -40.44% in the past year. This is quite bad
The Revenue for CLA have been decreasing by -22.02% on average. This is quite bad
EPS 1Y (TTM)40.05%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%497.85%
Revenue 1Y (TTM)-40.44%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%-2.36%
3.2 Future
CLA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.92% yearly.
The Revenue is expected to decrease by -37.74% on average over the next years. This is quite bad
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CLA is valuated reasonably with a Price/Forward Earnings ratio of 10.08.
CLA's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLA is cheaper than 90.35% of the companies in the same industry.
CLA is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.08 |
4.2 Price Multiples
CLA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLA is cheaper than 97.37% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 99.12% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.71 | ||
| EV/EBITDA | 3.49 |
4.3 Compensation for Growth
A cheap valuation may be justified as CLA's earnings are expected to decrease with -3.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.92%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CLA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:CLA (1/9/2026, 7:00:00 PM)
1.426
+0 (+0.28%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners5.13%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap81.58M
Revenue(TTM)293.80M
Net Income(TTM)-3.30M
Analysts80
Price Target2.45 (71.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.67%
EPS NY rev (3m)-36.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.08 | ||
| P/S | 0.28 | ||
| P/FCF | 2.71 | ||
| P/OCF | 2.21 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.49 |
EPS(TTM)-0.07
EYN/A
EPS(NY)0.14
Fwd EY9.92%
FCF(TTM)0.53
FCFY36.9%
OCF(TTM)0.64
OCFY45.23%
SpS5.14
BVpS-0.3
TBVpS-2.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.14% | ||
| ROE | N/A | ||
| ROCE | -1485% | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 10.11% | ||
| PM (TTM) | N/A | ||
| GM | 48.54% | ||
| FCFM | 10.25% |
ROA(3y)15.08%
ROA(5y)9.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.83%
ROIC(5y)14.14%
ROICexc(3y)41.64%
ROICexc(5y)35.57%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)22.9%
ROCE(5y)19.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-2.71%
ROICexc growth 5Y6.36%
OM growth 3Y58.64%
OM growth 5Y43.87%
PM growth 3YN/A
PM growth 5Y248.09%
GM growth 3Y26.81%
GM growth 5Y17.73%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 5.38 | ||
| Debt/EBITDA | 0.28 | ||
| Cap/Depr | 55.74% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 88.07% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.5 | ||
| Quick Ratio | 0.45 | ||
| Altman-Z | -0.25 |
F-Score6
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)69.81%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.05%
EPS 3YN/A
EPS 5Y152.38%
EPS Q2Q%497.85%
EPS Next Y-46.15%
EPS Next 2Y-3.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.44%
Revenue growth 3Y-37.08%
Revenue growth 5Y-22.02%
Sales Q2Q%-2.36%
Revenue Next Year-63.38%
Revenue Next 2Y-37.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.1%
EBIT growth 3Y-0.17%
EBIT growth 5Y12.2%
EBIT Next Year-17.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y18.97%
FCF growth 3Y14.47%
FCF growth 5Y-6.06%
OCF growth 1Y10.81%
OCF growth 3Y13.67%
OCF growth 5Y-4.45%
CLARANOVA SE / CLA.PA FAQ
Can you provide the ChartMill fundamental rating for CLARANOVA SE?
ChartMill assigns a fundamental rating of 3 / 10 to CLA.PA.
Can you provide the valuation status for CLARANOVA SE?
ChartMill assigns a valuation rating of 5 / 10 to CLARANOVA SE (CLA.PA). This can be considered as Fairly Valued.
How profitable is CLARANOVA SE (CLA.PA) stock?
CLARANOVA SE (CLA.PA) has a profitability rating of 4 / 10.
What is the financial health of CLARANOVA SE (CLA.PA) stock?
The financial health rating of CLARANOVA SE (CLA.PA) is 2 / 10.
Can you provide the expected EPS growth for CLA stock?
The Earnings per Share (EPS) of CLARANOVA SE (CLA.PA) is expected to decline by -46.15% in the next year.